Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole

Alexander Imhof, S. Arunmozhi Balajee, David N. Fredricks, Janet A. England, Kieren Marr

Research output: Contribution to journalArticle

Abstract

Infection with voriconazole-resistant fungi may become problematic, because organisms with decreased susceptibility have been noted. Breakthrough fungal infections occurred in 13 of 139 patients who received voriconazole at our center during the period of September 1998 through September 2003. Zygomycetes were found in 6 patients, and Candida glabrata bloodstream infection occurred in 4 patients. Minimal inhibitory concentrations were ≥ 1 μg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis.

Original languageEnglish (US)
Pages (from-to)743-746
Number of pages4
JournalClinical Infectious Diseases
Volume39
Issue number5
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Mycoses
Stem Cells
Transplants
Fungi
Infection
Candida glabrata
Aspergillosis
Yeasts
Voriconazole
Transplant Recipients

ASJC Scopus subject areas

  • Immunology

Cite this

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. / Imhof, Alexander; Balajee, S. Arunmozhi; Fredricks, David N.; England, Janet A.; Marr, Kieren.

In: Clinical Infectious Diseases, Vol. 39, No. 5, 01.09.2004, p. 743-746.

Research output: Contribution to journalArticle

Imhof, Alexander ; Balajee, S. Arunmozhi ; Fredricks, David N. ; England, Janet A. ; Marr, Kieren. / Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. In: Clinical Infectious Diseases. 2004 ; Vol. 39, No. 5. pp. 743-746.
@article{38be23f7f9734fa5b8f456b0502bdf40,
title = "Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole",
abstract = "Infection with voriconazole-resistant fungi may become problematic, because organisms with decreased susceptibility have been noted. Breakthrough fungal infections occurred in 13 of 139 patients who received voriconazole at our center during the period of September 1998 through September 2003. Zygomycetes were found in 6 patients, and Candida glabrata bloodstream infection occurred in 4 patients. Minimal inhibitory concentrations were ≥ 1 μg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis.",
author = "Alexander Imhof and Balajee, {S. Arunmozhi} and Fredricks, {David N.} and England, {Janet A.} and Kieren Marr",
year = "2004",
month = "9",
day = "1",
doi = "10.1086/423274",
language = "English (US)",
volume = "39",
pages = "743--746",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole

AU - Imhof, Alexander

AU - Balajee, S. Arunmozhi

AU - Fredricks, David N.

AU - England, Janet A.

AU - Marr, Kieren

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Infection with voriconazole-resistant fungi may become problematic, because organisms with decreased susceptibility have been noted. Breakthrough fungal infections occurred in 13 of 139 patients who received voriconazole at our center during the period of September 1998 through September 2003. Zygomycetes were found in 6 patients, and Candida glabrata bloodstream infection occurred in 4 patients. Minimal inhibitory concentrations were ≥ 1 μg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis.

AB - Infection with voriconazole-resistant fungi may become problematic, because organisms with decreased susceptibility have been noted. Breakthrough fungal infections occurred in 13 of 139 patients who received voriconazole at our center during the period of September 1998 through September 2003. Zygomycetes were found in 6 patients, and Candida glabrata bloodstream infection occurred in 4 patients. Minimal inhibitory concentrations were ≥ 1 μg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis.

UR - http://www.scopus.com/inward/record.url?scp=4444227169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444227169&partnerID=8YFLogxK

U2 - 10.1086/423274

DO - 10.1086/423274

M3 - Article

C2 - 15356792

AN - SCOPUS:4444227169

VL - 39

SP - 743

EP - 746

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -